DYAI Stock Summary and Trading Ideas (Dyadic International | NASDAQ:DYAI)

Dyadic International Inc is a biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.

Dyadic International trades on the NASDAQ stock market under the symbol DYAI.

As of August 12, 2026, DYAI stock price declined to $0.99 with 56,143 million shares trading.

DYAI has a beta of 1.50, meaning it tends to be more sensitive to market movements. DYAI has a correlation of 0.06 to the broad based SPY ETF.

DYAI has a market cap of $36.07 million. This is considered a Sub-Micro Cap stock.

Last quarter Dyadic International reported $1 million in Revenue and -$.05 earnings per share. This beat revenue expectation by $124,120 and missed earnings estimates by -$.02.

In the last 3 years, DYAI traded as high as $2.67 and as low as $.65.

The top ETF exchange traded funds that DYAI belongs to (by Net Assets): VTI, VXF.

DYAI has underperformed the market in the last year with a price return of +22.2% while the SPY ETF gained +22.6%. However, in the short term, DYAI had mixed performance relative to the market. It has outperformed in the last 3 months, returning +36.7% vs +4.7% return in SPY. But in the last 2 weeks, DYAI shares have been beat by the market, returning -6.6% compared to an SPY return of +4.2%.

DYAI support price is $.97 and resistance is $1.14 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DYAI shares will trade within this expected range on the day.